Documents
Application Sponsors
Marketing Status
Application Products
001 | SUSPENSION;ORAL | EQ 50MG BASE/ML | 1 | LEXIVA | FOSAMPRENAVIR CALCIUM |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2007-06-14 | PRIORITY |
LABELING; Labeling | SUPPL | 3 | AP | 2008-04-30 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2009-04-14 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2009-09-11 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2010-04-26 | UNKNOWN |
LABELING; Labeling | SUPPL | 10 | AP | 2011-05-10 | STANDARD |
EFFICACY; Efficacy | SUPPL | 12 | AP | 2012-04-27 | PRIORITY |
LABELING; Labeling | SUPPL | 13 | AP | 2012-02-17 | 901 REQUIRED |
LABELING; Labeling | SUPPL | 15 | AP | 2013-02-12 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 2015-07-17 | STANDARD |
LABELING; Labeling | SUPPL | 20 | AP | 2015-03-27 | 901 REQUIRED |
LABELING; Labeling | SUPPL | 21 | AP | 2016-03-22 | STANDARD |
LABELING; Labeling | SUPPL | 23 | AP | 2016-09-15 | STANDARD |
LABELING; Labeling | SUPPL | 24 | AP | 2017-12-01 | STANDARD |
LABELING; Labeling | SUPPL | 25 | AP | 2019-03-28 | STANDARD |
Submissions Property Types
SUPPL | 5 | Null | 7 |
SUPPL | 8 | Null | 7 |
SUPPL | 10 | Null | 7 |
SUPPL | 12 | Null | 7 |
SUPPL | 13 | Null | 7 |
SUPPL | 15 | Null | 7 |
SUPPL | 19 | Null | 7 |
SUPPL | 20 | Null | 15 |
SUPPL | 21 | Null | 6 |
SUPPL | 23 | Null | 15 |
SUPPL | 24 | Null | 6 |
SUPPL | 25 | Null | 6 |
CDER Filings
VIIV HLTHCARE
cder:Array
(
[0] => Array
(
[ApplNo] => 22116
[companyName] => VIIV HLTHCARE
[docInserts] => ["",""]
[products] => [{"drugName":"LEXIVA","activeIngredients":"FOSAMPRENAVIR CALCIUM","strength":"EQ 50MG BASE\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"03\/28\/2019","submission":"SUPPL-25","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021548s041,022116s025lbl.pdf\"}]","notes":""},{"actionDate":"03\/28\/2019","submission":"SUPPL-25","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021548s041,022116s025lbl.pdf\"}]","notes":""},{"actionDate":"12\/01\/2017","submission":"SUPPL-24","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/022116s024lbl.pdf\"}]","notes":""},{"actionDate":"12\/01\/2017","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/022116s024lbl.pdf\"}]","notes":""},{"actionDate":"09\/15\/2016","submission":"SUPPL-23","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/022116s023lbl.pdf\"}]","notes":""},{"actionDate":"09\/15\/2016","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/022116s023lbl.pdf\"}]","notes":""},{"actionDate":"03\/22\/2016","submission":"SUPPL-21","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021548s037,022116s021lbl.pdf\"}]","notes":""},{"actionDate":"07\/17\/2015","submission":"SUPPL-19","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021548s035,022116s019lbl.pdf\"}]","notes":""},{"actionDate":"07\/17\/2015","submission":"SUPPL-19","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021548s035,022116s019lbl.pdf\"}]","notes":""},{"actionDate":"03\/27\/2015","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022116s020,021548s036lbl.pdf\"}]","notes":""},{"actionDate":"03\/27\/2015","submission":"SUPPL-20","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022116s020,021548s036lbl.pdf\"}]","notes":""},{"actionDate":"03\/27\/2015","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022116s020,021548s036lbl.pdf\"}]","notes":""},{"actionDate":"02\/12\/2013","submission":"SUPPL-15","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021548s031,022116s015lbl.pdf\"}]","notes":""},{"actionDate":"02\/12\/2013","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021548s031,022116s015lbl.pdf\"}]","notes":""},{"actionDate":"04\/27\/2012","submission":"SUPPL-12","supplementCategories":"Efficacy-Pediatric","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/021548s028,022116s012lbl.pdf\"}]","notes":""},{"actionDate":"02\/17\/2012","submission":"SUPPL-13","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/021548s029,022116s013lbl.pdf\"}]","notes":""},{"actionDate":"05\/10\/2011","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021548s026,022116s010lbl.pdf\"}]","notes":""},{"actionDate":"05\/10\/2011","submission":"SUPPL-10","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021548s026,022116s010lbl.pdf\"}]","notes":""},{"actionDate":"04\/26\/2010","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021548s024,022116s008lbl.pdf\"}]","notes":""},{"actionDate":"09\/11\/2009","submission":"SUPPL-5","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/021548s021,022116s005lbl.pdf\"}]","notes":""},{"actionDate":"03\/05\/2008","submission":"SUPPL-1","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021548s017,022116s001lbl.pdf\"}]","notes":""},{"actionDate":"06\/14\/2007","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/022116lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"LEXIVA","submission":"FOSAMPRENAVIR CALCIUM","actionType":"EQ 50MG BASE\/ML","submissionClassification":"SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-03-28
)
)